Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

News

 

3R buys in Switzerland and looks at France

Naxicap-owned imaging group 3R Réseau Radiologique Romand has bought IRIS Radiologie and is eyeing up France. Germany and Italy are also possibles, HBI hears.
July 7, 2022

Swiss labs suffer 10% cut, more may follow

Switzerland has chopped its diagnostic lab prices by 10% in a move that is billed as saving CHf 140m (€141). There could well be further crackdowns following a publication highlighting the massive differences between Swiss prices and those in France, Germany and the Netherlands.
July 7, 2022

New pricing engine allows Spire to capitalise on self-pay

Spire Healthcare, one of the UK’s largest private hospital groups, unveiled its new ‘pricing engine’ at their capital markets day this week - a computer programme which calculates optimal prices based on data about competitor pricing, procedures, inflation, and location, to automate price changes much quicker than was possible previously.
July 1, 2022

HBI 2022: Rosy future for dentistry, despite resurfacing threats

Pre-Covid, dentistry was seen as one of the hot tickets of healthcare services, largely unconsolidated, and attracting huge interest, not least from private equity. Covid took its toll but as the threat from the pandemic recedes in Europe, the focus has shifted back onto the opportunities in the sector – and onto other, longer-lasting problems like staffing, training, and the threat of recession. Despite these threats, according to a panel at HBI 2022, the future for the sector looks bright.
July 1, 2022

HBI 2022: Resilient fertility a “ridiculously positive market”

Resilient, recession-proof fertility has a strong future ahead, but will face some challenges in the coming months according to an HBI 2022 panel. Demand is strong, patients came back quickly when clinics - and borders - reopened, and the threat of recession is not causing anyone to lose sleep. 
July 1, 2022

HBI 2022: Panel sees a rosy future for ophthalmology

Ophthalmology continues to be a big area of investor interest, with considerable scope for consolidation in both healthcare services and also medical devices. As governments in the UK, Finland and parts of Eastern Europe in particular continue to increase outsourcing, the potential to unlock additional private pay services is increasing, and upselling of more complex lenses is on the rise. An expert panel convened at HBI 2022 to discuss the opportunities and challenges in the post-pandemic landscape.
July 1, 2022

HBI 2022: Balance of power in MENA is shifting

There is a risk, when looking at healthcare markets in MENA, of lumping all the countries together as one - but each market has very specific requirements, and very specific characteristics. A panel at HBI 2022 chaired by Hamid Yunis, partner at global law firm McDermott Will & Emery, investigated challenges and opportunities in the region - and how rapidly the markets are changing and why overseas players now need to work harder to impress.
July 1, 2022
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us